Affordable and Safe Prescription Drug Importation Act
- Last Action
- 1/25/2019
Actions
- 2019-01-25Referred to the Subcommittee on Health.
- 2019-01-10Referred to the House Committee on Energy and Commerce.
- 2019-01-10Introduced in House
- 2019-01-10Introduced in House
CRS Summary
As of 2019-01-10 (00)
Affordable and Safe Prescription Drug Importation Act
This bill addresses the importation of drugs from Canada and other foreign countries.
The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries.
The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
Cosponsors (20)
- LLOYD DOGGETT (D-TX)
- Peter Welch (D-VT)
- Steve Cohen (D-TN)
- Ro Khanna (D-CA)
- BARBARA LEE (D-CA)
- ELEANOR NORTON (D-DC)
- Chellie Pingree (D-ME)
- ROSA DELAURO (D-CT)
- BRAD SHERMAN (D-CA)
- Mark Pocan (D-WI)
- Pramila Jayapal (D-WA)
- Ilhan Omar (D-MN)
- Raja Krishnamoorthi (D-IL)
- Tulsi Gabbard (D-HI)
- JAMES LANGEVIN (D-RI)
- SHEILA JACKSON LEE (D-TX)
- EARL BLUMENAUER (D-OR)
- JANICE SCHAKOWSKY (D-IL)
- Joe Neguse (D-CO)
- Alexandria Ocasio-Cortez (D-NY)
Subjects
- Administrative law and regulatory procedures
- Canada
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Government studies and investigations
- Prescription drugs
- Trade restrictions
- User charges and fees
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.